Evidence map›Paper›PMID 33560041›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2021

Population Viral Load, Viremia, and Recent HIV-1 Infections: Findings From Population-Based HIV Impact Assessments (PHIAs) in Zimbabwe, Malawi, and Zambia.

Mansoor Farahani, Elizabeth Radin, Suzue Saito, Karampreet K Sachathep, Wolfgang Hladik, Andrew C Voetsch, Andrew F Auld, Shirish Balachandra, Beth A Tippett Barr, Andrea Low and 15 more

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 3 countries.

Mansoor FarahaniICAP at Columbia University, New York, NY.
Elizabeth RadinICAP at Columbia University, New York, NY.
Suzue SaitoICAP at Columbia University, New York, NY.
Karampreet K SachathepICAP at Columbia University, New York, NY.
Wolfgang HladikDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Andrew C VoetschDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Andrew F AuldDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Malawi.
Shirish BalachandraDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Côte d'Ivoire.
Beth A Tippett BarrDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Zimbabwe.
Andrea LowICAP at Columbia University, New York, NY.
Theodore F SmartICAP at Columbia University, New York, NY.
Godfrey MusukaICAP at Columbia University, Zimbabwe.
Sasi JonnalagaddaDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Avi J HakimDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Nellie W Wadonda-KabondoDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Malawi.
Andreas JahnITECH-Malawi, Lilongwe, Malawi.
Owen MugurungiMinistry of Health and Child Care, Zimbabwe.
Daniel B WilliamsDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Danielle T BarradasDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Zambia and.
Danielle PayneDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Malawi.
Bharat ParekhDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Hetal PatelDivision of Global HIV&TB, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Lubbe WiesnerPharmacology Research Laboratory, University of Cape Town, Cape Town, South Africa; and.
David HoosICAP at Columbia University, New York, NY.
Jessica E JustmanICAP at Columbia University, New York, NY.
Centers for Disease Control and Prevention · USColumbia University · USICAP Global HealthMinistry of Health and Child Welfare · ZWUniversity of Cape Town · ZA

Funding

CGH CDC HHS U2G GH001226PEPFAR
6 · The paper itself

Abstract

backgroundHIV population viral load (PVL) can reflect antiretroviral therapy program effectiveness and transmission potential in a community. Using nationally representative data from household surveys conducted in Zimbabwe, Malawi, and Zambia in 2015-16, we examined the association between various VL measures and the probability of at least one recent HIV-1 infection in the community.

methodsWe used limiting-antigen avidity enzyme immunoassay, viral load suppression (VLS) (HIV RNA <1000 copies/mL), and antiretrovirals in the blood to identify recent HIV-1 cases.

resultsAmong 1510 enumeration areas (EAs) across the 3 surveys, 52,036 adults aged 15-59 years resided in 1363 (90.3%) EAs with at least one HIV-positive adult consenting to interview and blood draw and whose VL was tested. Mean HIV prevalence across these EAs was 13.1% [95% confidence intervals (CI) 12.7 to 13.5]. Mean VLS prevalence across these EAs was 58.7% (95% CI: 57.3 to 60.0). In multivariable analysis, PVL was associated with a recent HIV-1 case in that EA (adjusted odds ratio: 1.4, 95% CI: 1.2 to 1.6, P = 0.001). VLS prevalence was inversely correlated with recent infections (adjusted odds ratio: 0.3, 95% CI: 0.1 to 0.6, P = 0.004). The 90-90-90 indicators, namely, the prevalence of HIV diagnosis, antiretroviral therapy coverage, and VLS at the EA level, were inversely correlated with HIV recency at the EA level.

conclusionsWe found a strong association between PVL and VLS prevalence and recent HIV-1 infection at the EA level across 3 southern African countries with generalized HIV epidemics. These results suggest that population-based measures of VLS in communities may serve as a proxy for epidemic control.

Indexed as

HIV-1Viral LoadViremiaEpidemiological MonitoringHealth SurveysHIV InfectionsHumansMalawiZambiaZimbabwe

Identifiers

PMID33560041
PMCPMC10998157
OpenAlexW3128327437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.